{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Uneven distribution of vaccination\",\"Impact\":\"Increased risk of disease spread and mutation, higher mortality rates in underserved populations\",\"Mitigation\":\"Implementing a fair distribution system, prioritizing vulnerable groups, and addressing disparities\",\"Technologies\":\"Data-driven allocation algorithms, cold chain logistics, and tracking systems\",\"People\":\"Underserved populations, older persons, high-risk individuals, people with co-morbidities\",\"Owner\":\"Government agencies, international health organizations, and NGOs\"},{\"Description\":\"Vaccine hesitancy\",\"Impact\":\"Slower achievement of herd immunity, increased transmission of the disease, and ongoing public health risks\",\"Mitigation\":\"Culturally tailored communication, community engagement, and robust pharmacovigilance to address concerns and build trust\",\"Technologies\":\"Data analytics for tailored messaging, social media monitoring, and adverse event monitoring systems\",\"People\":\"General population, especially in low-income and high-income countries\",\"Owner\":\"Health authorities, community leaders, and public health organizations\"},{\"Description\":\"Intellectual Property Rights and affordability\",\"Impact\":\"Limited access to essential vaccines, potentially hindering global vaccination efforts and disease control\",\"Mitigation\":\"Negotiating IP rights, increasing production capacity, and enhancing affordability through global partnerships\",\"Technologies\":\"Biotechnology for vaccine development, manufacturing automation, and cost-effective production methods\",\"People\":\"Global population, especially in low-income countries\",\"Owner\":\"Global health organizations, governments, and pharmaceutical companies\"}]}"}}